Back

Early commencement of tolvaptan therapy improves clinical outcomes in heart failure patients with preserved function of renal vasopressin V2 receptors

25 August 2018 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Chronic heart failure – Treatment Pharmacotherapy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Takahiro Noto

Sapporo Medical University, Sapporo (Japan)

7 More presentations in this session

Presentation thumbnail
Professor C. Lang (Dundee, GB)
Abstract
Presentation thumbnail
Doctor K. Tsuda (Takatsuki, JP)
Abstract
Presentation thumbnail
Associate Professor R. Wachter (Leipzig, DE)
Abstract Slides
Presentation thumbnail
Professor U. Zeymer (Ludwigshafen, DE)
Abstract
Presentation thumbnail
Professor P. Leszek (Warsaw, PL)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Chronic heart failure – Treatment

The Event

Event poster

ESC Congress 2018

25 August 2018 11:00 CET
You may be interested in
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023
thumbnail
Webinar
MRAs in heart failure: what's old is new again

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources